Exonomo

faqs

1. What is Exonomo Capital?

Exonomo Capital is a founder-led investment firm that bridges the gap between healthcare real estate and next-generation healthtech. We invest in senior living facilities today and plan to expand into healthtech startups tomorrow.

We focus on two core areas:

Healthcare Real Estate: Including independent and assisted living facilities (ILFs and ALFs).

Healthtech Innovation: Digital health platforms, AI tools, telemedicine, and other transformative healthcare technologies.

HEALIT (Holistic care, Equity, Access, Longevity, Innovation, and Trust) is our flagship real estate fund dedicated to developing and operating senior care communities with built-in potential for technology integration.

VITRA (Ventures in Innovative Technologies, Robotics, and AI) is our venture capital fund targeting early- to growth-stage healthtech startups focused on improving healthcare outcomes, access, and efficiency.

Our leadership team includes experienced healthcare entrepreneurs and investors. Co-founders Naweed Muhammad and Kashif Ali Rana serve as Managing Partners, supported by a network of advisors in real estate, compliance, and tech.

We work primarily with accredited investors, family offices, and institutions. You can reach out via our contact form to schedule a conversation. Investments are made through a formal subscription and due diligence process.

The minimum investment for our HEALIT Fund is $100,000, unless waived by the General Partner. The VITRA Fund has a flexible structure depending on the funding round.

Our goal is to deliver both strong financial returns and measurable healthcare impact. HEALIT aims for stable cash flow from real estate assets, while VITRA targets higher-growth equity outcomes from innovative startups.

We are hands-on partners. From operational guidance to technology implementation, we support each project or startup with strategic input, healthcare insights, and access to real-world pilot environments.

We provide regular quarterly updates, including financial performance, strategic progress, and key metrics. Our investors enjoy direct access to our team for deeper discussions and transparency.